AA
OCEA

ACT Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

ACT Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,911
Closed -$8.8K – 66
2024
Q4 		$8.8K Sell
15,911
-790
-5% -$622 ﹤0.01% 55
2024
Q3 		$16.4K Buy
16,701
+69
+0.4% +$74 0.01% 51
2024
Q2 		$20.3K Buy
16,632
+5
+0% +$9 0.01% 45
2024
Q1 		$62.9K Buy
+16,627
New +$31.3K 0.03% 42

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RWP
Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACT Advisors's OCEA Position: Q1 2025 in Review

ACT Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2025, closing a stake of 15,911 shares — an estimated $8.8K sold.

ACT Advisors first reported a position in OCEA in Q1 2024 and held it in 4 quarters. The position peaked at $62.9K in Q1 2024. 25 funds tracked by Wall St. Rank hold OCEA as of Q1 2025.

  • ACT Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • ACT Advisors sold 15,911 Ocean Biomedical, Inc. Common Stock shares in Q1 2025, an estimated $8.8K.
  • ACT Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • ACT Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $62.9K in Q1 2024.
  • 25 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2025.

Based on ACT Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.